Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Nuclear Medicine Diagnostics Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Nuclear Medicine Diagnostics Market Performance
• 2.3 USA Nuclear Medicine Diagnostics Market Performance
• 2.4 Europe Nuclear Medicine Diagnostics Market Performance
• 2.5 Japan Nuclear Medicine Diagnostics Market Performance
• 2.6 Korea Nuclear Medicine Diagnostics Market Performance
• 2.7 India Nuclear Medicine Diagnostics Market Performance
• 2.8 Southeast Asia Nuclear Medicine Diagnostics Market Performance
• 2.9 South America Nuclear Medicine Diagnostics Market Performance

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
• 3.2 China Nuclear Medicine Diagnostics Market Performance (Volume)
• 3.3 USA Nuclear Medicine Diagnostics Market Performance (Volume)
• 3.4 Europe Nuclear Medicine Diagnostics Market Performance (Volume)
• 3.5 Japan Nuclear Medicine Diagnostics Market Performance (Volume)
• 3.6 Korea Nuclear Medicine Diagnostics Market Performance (Volume)
• 3.7 India Nuclear Medicine Diagnostics Market Performance (Volume)
• 3.8 Southeast Asia Nuclear Medicine Diagnostics Market Performance (Volume)
• 3.9 South America Nuclear Medicine Diagnostics Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Agfa-Gevaert
  • 4.1.1 Agfa-Gevaert Profiles
  • 4.1.2 Agfa-Gevaert Product Information
  • 4.1.3 Agfa-Gevaert Nuclear Medicine Diagnostics Business Performance
  • 4.1.4 Agfa-Gevaert Nuclear Medicine Diagnostics Business Development and Market Status
• 4.2 Cardiarc
  • 4.2.1 Cardiarc Profiles
  • 4.2.2 Cardiarc Product Information
  • 4.2.3 Cardiarc Nuclear Medicine Diagnostics Business Performance
  • 4.2.4 Cardiarc Nuclear Medicine Diagnostics Business Development and Market Status
• 4.3 Digirad Corporation
  • 4.3.1 Digirad Corporation Profiles
  • 4.3.2 Digirad Corporation Product Information
  • 4.3.3 Digirad Corporation Nuclear Medicine Diagnostics Business Performance
  • 4.3.4 Digirad Corporation Nuclear Medicine Diagnostics Business Development and Market Status
• 4.4 Gamma Medica
  • 4.4.1 Gamma Medica Profiles
  • 4.4.2 Gamma Medica Product Information
  • 4.4.3 Gamma Medica Nuclear Medicine Diagnostics Business Performance
  • 4.4.4 Gamma Medica Nuclear Medicine Diagnostics Business Development and Market Status
• 4.5 GE Healthcare
  • 4.5.1 GE Healthcare Profiles
  • 4.5.2 GE Healthcare Product Information
  • 4.5.3 GE Healthcare Nuclear Medicine Diagnostics Business Performance
  • 4.5.4 GE Healthcare Nuclear Medicine Diagnostics Business Development and Market Status
• 4.6 Hologic
  • 4.6.1 Hologic Profiles
  • 4.6.2 Hologic Product Information
  • 4.6.3 Hologic Nuclear Medicine Diagnostics Business Performance
  • 4.6.4 Hologic Nuclear Medicine Diagnostics Business Development and Market Status
• 4.7 BC Technical
  • 4.7.1 BC Technical Profiles
  • 4.7.2 BC Technical Product Information
  • 4.7.3 BC Technical Nuclear Medicine Diagnostics Business Performance
  • 4.7.4 BC Technical Nuclear Medicine Diagnostics Business Development and Market Status
• 4.8 CMR Naviscan
  • 4.8.1 CMR Naviscan Profiles
  • 4.8.2 CMR Naviscan Product Information
  • 4.8.3 CMR Naviscan Nuclear Medicine Diagnostics Business Performance
  • 4.8.4 CMR Naviscan Nuclear Medicine Diagnostics Business Development and Market Status
• 4.9 Positron Corporation
  • 4.9.1 Positron Corporation Profiles
  • 4.9.2 Positron Corporation Product Information
  • 4.9.3 Positron Corporation Nuclear Medicine Diagnostics Business Performance
  • 4.9.4 Positron Corporation Nuclear Medicine Diagnostics Business Development and Market Status
• 4.10 Segami Corporation
  • 4.10.1 Segami Corporation Profiles
  • 4.10.2 Segami Corporation Product Information
  • 4.10.3 Segami Corporation Nuclear Medicine Diagnostics Business Performance
  • 4.10.4 Segami Corporation Nuclear Medicine Diagnostics Business Development and Market Status
• 4.11 Philips Healthcare
• 4.12 Siemens
• 4.20 Segami Corporation

5 Market Performance for Manufacturers

• 5.1 Global Nuclear Medicine Diagnostics Production (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Nuclear Medicine Diagnostics Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Nuclear Medicine Diagnostics Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Nuclear Medicine Diagnostics Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Global Nuclear Medicine Diagnostics Market Performance (Production Point)

• 6.1 Global Nuclear Medicine Diagnostics Production (K Units) and Market Share by Regions 2013-2018
• 6.2 Global Nuclear Medicine Diagnostics Revenue (M USD) and Market Share by Regions 2013-2018
• 6.3 Global Nuclear Medicine Diagnostics Price (USD/Unit) by Regions 2013-2018
• 6.4 Global Nuclear Medicine Diagnostics Gross Margin by Regions 2013-2018

7 Development Trend for Regions (Production Point)

• 7.1 Global Nuclear Medicine Diagnostics Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
• 7.2 China Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.3 USA Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.4 Europe Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.5 Japan Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.6 Korea Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.7 India Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.8 Southeast Asia Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.9 South America Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

8 Global Nuclear Medicine Diagnostics Market Performance (Consumption Point)

• 8.1 Global Nuclear Medicine Diagnostics Consumption and Market Share by Regions 2013-2018
• 8.2 Global Nuclear Medicine Diagnostics Consumption Value and Market Share by Regions 2013-2018
• 8.3 Global Nuclear Medicine Diagnostics Price (USD/Unit) by Regions 2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global Nuclear Medicine Diagnostics Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China Nuclear Medicine Diagnostics Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA Nuclear Medicine Diagnostics Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe Nuclear Medicine Diagnostics Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan Nuclear Medicine Diagnostics Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea Nuclear Medicine Diagnostics Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India Nuclear Medicine Diagnostics Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia Nuclear Medicine Diagnostics Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America Nuclear Medicine Diagnostics Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Application 1 Industry
• 12.2 Application 2 Industry

13 Market Forecast 2019-2024

• 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 13.1.2 Global Nuclear Medicine Diagnostics Production (K Units) and Growth Rate 2019-2024
  • 13.1.3 China Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America Nuclear Medicine Diagnostics Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.2 Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.1 Global Nuclear Medicine Diagnostics Consumption and Market Share by Regions 2019-2024
  • 13.2.2 Global Nuclear Medicine Diagnostics Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.3 China Nuclear Medicine Diagnostics Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.4 USA Nuclear Medicine Diagnostics Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.5 Europe Nuclear Medicine Diagnostics Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.6 Japan Nuclear Medicine Diagnostics Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.7 Korea Nuclear Medicine Diagnostics Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.8 India Nuclear Medicine Diagnostics Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.9 Southeast Asia Nuclear Medicine Diagnostics Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.10 South America Nuclear Medicine Diagnostics Sales, Sales Value and Growth Rate 2019-2024
• 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Type I Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 Type II Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Application 1 Sales and and Growth Rate 2019-2024
  • 13.4.3 Application 2 Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global Nuclear Medicine Diagnostics Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global Nuclear Medicine Diagnostics Gross Profit Trend 2019-2024

14 Conclusion

Geographically, global Nuclear Medicine Diagnostics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Agfa-Gevaert
Cardiarc
Digirad Corporation
Gamma Medica
GE Healthcare
Hologic
BC Technical
CMR Naviscan
Positron Corporation
Segami Corporation
Philips Healthcare
Siemens

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Type I
Type II
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Nuclear Medicine Diagnostics for each application, including
Application 1
Application 2
Production, consumption, revenue, market share and growth rate are the key targets for Nuclear Medicine Diagnostics from 2013 to 2024 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.